1293987-57-1

Basic information

• Product Name: N-(3-(2-chlorothieno[3,2-d]pyrimidin-7-yl)phenyl)-methanesulfonamide
• Synonyms: N-(3-(2-chlorothieno[3,2-d]pyrimidin-7-yl)phenyl)-methanesulfonamide
• CAS NO: 1293987-57-1
• Molecular Weight: 339.826
• Mol File: 1293987-57-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-(3-(2-chlorothieno[3,2-d]pyrimidin-7-yl)phenyl)-methanesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-(2-chlorothieno[3,2-d]pyrimidin-7-yl)phenyl)-methanesulfonamide(1293987-57-1)
• EPA Substance Registry System: N-(3-(2-chlorothieno[3,2-d]pyrimidin-7-yl)phenyl)-methanesulfonamide(1293987-57-1)

Safety Data

• Hazardous Substances Data: 1293987-57-1(Hazardous Substances Data)

Upstream product

• 1152475-42-7 7-bromo-2-chlorothieno[3,2-d]pyrimidine 
• 148355-75-3 3-(methylsulfonamido)phenylboronic acid 
• 1293987-55-9 7-bromo-2-chloro-3,4-dihydrothieno[3,2-d]pyrimidine 
• 22288-78-4 Methyl 3-aminothiophene-2-carboxylate 
• 41102-25-4 7-bromo-2,4-dichloroimidazo[2,1-f][1,2,4]triazine 
• 41102-02-7 7-bromothieno[3,2-d]pyrimidine-2,4(1H,3H)-dione 
• 16233-51-5 1H-thieno[3,2-d]pyrimidine-2,4-dione 
• 1293987-56-0 3-(2-chlorothieno[3,2-d]pyrimidin-7-yl)benzenamine 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 1293987-76-4 N-(3-(2-chlorothieno[3,2-d]pyrimidin-7-yl)phenyl)-N-methylmethanesulfonamide 
• 1293987-54-8 N-(3-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-ylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)methanesulfonamide hydrochloride 
• 1293987-05-9 N-(3-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-ylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)methanesulfonamide 
• 1293987-60-6 N-(3-(2-aminothieno[3,2-d]pyrimidin-7-yl)phenyl)-methanesulfonamide 
• 1152473-72-7 N-(3-(2-(4-morpholinophenylamino)thieno[3,2-d]pyrimidin-7-yl)phenyl)methanesulfonamide 

Relevant articles and documents

Identification of Thieno[3,2- d]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3

Focal adhesion kinase (FAK) is overexpressed in highly invasive and metastatic cancers. To identify novel FAK inhibitors, we designed and synthesized various thieno[3,2-d]pyrimidine derivatives. An intensive structure-activity relationship (SAR) study led

2,7-SUBSTITUTED THIENO[3,2-D]PYRIMIDINE COMPOUNDS AS PROTEIN KINASE INHIBITORS

Disclosed are a 2,7-substituted thieno[3,2-d]pyrimidine compound having a protein kinase inhibition activity, a pharmaceutically acceptable salt, and a pharmaceutical composition for prevention and treatment of diseases caused by abnormal cell growth comp